- Invested $35M in R&D and testing over the past three years, with $50M more planned.
- Over $200M invested in a new plant in China.
- Hazelwood center upgrades include new NMR capabilities.
- Field Testing Center to support data collection starting later this year.
Investment in R&D and Testing
In the past three years, Lubrizol has invested over $35 million in R&D and testing activities, with an additional $50 million budgeted for the next three years. This is part of a broader capital investment strategy, which includes more than $200 million allocated for a new plant in China.
Hazelwood Technical Center Upgrades
Significant investments are being made at Lubrizol’s global technical center in Hazelwood, UK. These include major upgrades to chemical testing laboratories and ongoing improvements to the chemical synthesis facility. The size of the chemical synthesis team at Hazelwood has nearly doubled in the past decade, necessitating these enhancements.
Advanced NMR Capabilities
To ensure efficient chemical synthesis and superior customer service, Lubrizol has acquired state-of-the-art nuclear magnetic resonance (NMR) capabilities at the Hazelwood site. NMR spectroscopy is crucial for obtaining detailed information about molecules, and the new NMR suite will accelerate the development of new molecules and provide faster analysis for problem-solving.
Field Testing Center and Future Plans
Many updates to the Hazelwood technical facility will be completed by the end of this year, with further extensive upgrades planned over the next two years. A new Field Testing Center will soon support the collection of over one million kilometers of data gathered weekly on Lubrizol products. Additionally, the laboratory blend room capabilities will be expanded later this year.
